SCHEMBL6554732

SCHEMBL6554732

C=C(COc1ccc(CCNC(=O)C(CC)NS(=O)(=O)CC)cc1OC)c1ccc(Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
GAA P10253 2/20 0.52
ALDH1A1 P00352 3/20 0.46
CNR1 P21554 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.44
LMNA P02545 3/20 0.44
CTSD P07339 2/20 0.44
TP53 P04637 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
THRB P10828 1/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6554726 1.00 MEN1 (0.53) MEN1KMT2AGAAALDH1A1CNR1
SCHEMBL6556893 0.90 GAA (0.52) MEN1KMT2AGAAALDH1A1CNR1
SCHEMBL6555985 0.85 KMT2A (0.55) MEN1KMT2AGAAALDH1A1CNR1
SCHEMBL7156842 0.85 KMT2A (0.55) MEN1KMT2AGAAALDH1A1CNR1
SCHEMBL7157119 0.84 GAA (0.52) MEN1KMT2AGAAALDH1A1CNR1
SCHEMBL6553333 0.84 MEN1 (0.56) MEN1KMT2AGAAALDH1A1CNR1
SCHEMBL6553342 0.84 MEN1 (0.56) MEN1KMT2AGAAALDH1A1CNR1
SCHEMBL6556806 0.79 KMT2A (0.58) MEN1KMT2AGAAALDH1A1CNR1
SCHEMBL6554770 0.78 ALDH1A1 (0.58) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL6554757 0.78 ALDH1A1 (0.58) MEN1KMT2AALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1135368-B1 ALPHA-SULFIN- AND ALPHA-SULFON-AMINO ACID AMIDES SYNGENTA PARTICIPATIONS AG (CH) 2004-02-25 EP disclosed
US-6538016-B2 For controlling and preventing an infestation of crop plants by phytopathogenic microorganisms, preferably fungi SYNGENTA PARTICIPATIONS AG (CH) 2003-03-25 US disclosed
US-20020082452-A1 alpha-sulfin-and alpha-sulfonamino acid amides SYNGENTA PARTICIPATIONS AG (CH) 2002-06-27 US disclosed
EP-1135368-A2 ALPHA-SULFIN- AND ALPHA-SULFON-AMINO ACID AMIDES Syngenta Participations AG (CH) 2001-09-26 EP disclosed
WO-2000032568-A2 $G(A)-SULFIN- AND $G(A)-SULFONAMINO ACID AMIDES SYNGENTA PARTICIPATIONS AG (CH) 2000-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020082452-A1 alpha-sulfin-and alpha-sulfonamino acid amides SULT1A1, CBR1, SULT2A1 MEN1 3649/4885KMT2A 2647/4885GAA 2769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.